BIO 协议：深入探讨孵化专业 BioDAO 的 DeSci 平台

BIO Protocol 代币发行前夕，DeSci（去中心化科学）生态系统中的代币价格飙升。作为之间的界限

On the eve of the BIO Protocol token issuance, the price of tokens in the DeSci (decentralized science) ecosystem soared to new heights. This astronomical rise in value was fueled by the anticipation surrounding BIO's entry into the Web3 scene. As the boundaries between cutting-edge technologies blurred, this enthusiasm extended to tokens related to both DeSci and AI, creating a synergy that propelled their collective performance.

BIO Protocol 代币发行前夕，DeSci（去中心化科学）生态系统中的代币价格飙升至新高。人们对 BIO 进入 Web3 领域的预期推动了价值的天文数字般的上涨。随着尖端技术之间的界限变得模糊，这种热情延伸到了与 DeSci 和 AI 相关的代币，产生了协同效应，推动了它们的集体表现。

Being a key hub for DeSci financing, the launch of BIO brought immense hope to the DeSci community. It spurred the outside world's enthusiasm for this highly experimental field, attracting more attention and capital to DeSci over time. This article will delve into the inner workings of the BIO Protocol, exploring how it tackles challenges in the biotech space and highlighting the DAOs that operate under its umbrella. We will then examine how other projects contribute to the DeSci narrative, offering additional tools or use cases to revolutionize scientific collaboration and funding.

作为 DeSci 融资的重要枢纽，BIO 的推出给 DeSci 社区带来了巨大的希望。它激发了外界对这个高度实验性领域的热情，随着时间的推移，为 DeSci 吸引了更多的关注和资本。本文将深入探讨 BIO 协议的内部运作，探讨它如何应对生物技术领域的挑战，并重点介绍在其保护伞下运作的 DAO。然后，我们将研究其他项目如何为 DeSci 叙述做出贡献，提供额外的工具或用例来彻底改变科学合作和资助。

Delving into the BIO Protocol

深入研究 BIO 协议

At its core, BIO Protocol is a decentralized, token-managed platform that nurtures and supports specialized BioDAOs. By shifting funding decisions, intellectual property ownership, and governance on-chain, BIO directly addresses several long-standing obstacles in the biotech space:

BIO Protocol 的核心是一个去中心化、代币管理的平台，用于培育和支持专门的 BioDAO。通过改变融资决策、知识产权所有权和链上治理，BIO 直接解决了生物技术领域的几个长期存在的障碍：

- Funding bottlenecks: Despite promising research, scientists often struggle to secure funding due to the centralized and opaque nature of traditional funding bodies.

- 资金瓶颈：尽管研究前景广阔，但由于传统资助机构的集中性和不透明性，科学家们常常难以获得资金。

- Slow research pace: Lengthy bureaucracy and a lack of clear incentives hinder the research process, delaying the application of new discoveries.

- 研究进度缓慢：冗长的官僚机构和缺乏明确的激励措施阻碍了研究进程，延迟了新发现的应用。

- Limited IP ownership: Researchers typically cede ownership of their discoveries to their institutions or funding bodies, hampering their ability to fully benefit from future commercialization.

- 有限的知识产权所有权：研究人员通常会将其发现的所有权转让给其机构或资助机构，从而妨碍他们从未来的商业化中充分受益的能力。

To achieve its goals, BIO implements several core mechanisms:

为了实现其目标，BIO 实施了几个核心机制：

1. Curation

1. 策展

BIO holders lock up their tokens (vBIO) to help determine which new BioDAOs are allowed to join the network. This process ensures that only the most promising or community-backed ventures join, as those who pledge their support must stake BIO for a certain period of time. If approved, stakers have exclusive access to the BioDAO's funding rounds.

BIO 持有者锁定他们的代币（vBIO），以帮助确定允许哪些新的 BioDAO 加入网络。这个过程确保只有最有前途或社区支持的企业才能加入，因为那些承诺支持的企业必须在一段时间内持有 BIO。如果获得批准，利益相关者可以独家参与 BioDAO 的融资轮次。

2. Funding and Liquidity

2. 资金和流动性

After completing the curation phase, BioDAO opens a private pre-seed auction for those who lock in vBIO. This allows early backers of the DAO and the BIO community to invest in early scientific research on terms traditionally reserved for VCs. At the same time, the BIO Protocol manages liquidity on behalf of these BioDAOs, eliminating the need to monitor secondary markets. The BIO Treasury pairs tokens (i.e. VITA/BIO or HAIR/BIO) with ETH or other assets, generating fees for the protocol while ensuring stable trading pairs. This arrangement allows BioDAOs to focus on advancing research rather than being bogged down by market operations.

完成管理阶段后，BioDAO 为那些锁定 vBIO 的人举办私人种子前拍卖。这使得 DAO 和 BIO 社区的早期支持者能够以传统上为 VC 保留的术语投资于早期科学研究。同时，BIO 协议代表这些 BioDAO 管理流动性，从而无需监控二级市场。 BIO Treasury 将代币（即 VITA/BIO 或 HAIR/BIO）与 ETH 或其他资产配对，为协议产生费用，同时确保稳定的交易对。这种安排使 BioDAO 能够专注于推进研究，而不是陷入市场运营的困境。

3. Meta-governance

3.元治理

Because the BIO Treasury holds a portion of every BioDAO token, BIO holders collectively gain influence within the broader DeSci ecosystem. This meta-governance structure enables them to guide multiple BioDAO decisions, whether it’s determining research priorities or highlighting synergies between projects. Additionally, by diversifying the assets held in the treasury, the protocol enhances its ability to invest in new projects and reinvest in existing ones, enabling seamless coordination across an ever-expanding scientific research landscape.

由于 BIO Treasury 持有每个 BioDAO 代币的一部分，因此 BIO 持有者共同在更广泛的 DeSci 生态系统中获得影响力。这种元治理结构使他们能够指导多项 BioDAO 决策，无论是确定研究重点还是强调项目之间的协同作用。此外，通过使金库中持有的资产多样化，该协议增强了投资新项目和再投资现有项目的能力，从而在不断扩大的科学研究领域实现无缝协调。

4. Providing benefits

4. 提供福利

To incentivize clear, measurable contributions to its network, BIO issues “bio/acc rewards” in the form of additional BIO tokens to BioDAOs that achieve key milestones. In addition to these incentives, BioDAOs can tokenize their IP, ranging from research data to patents. By issuing IP tokens, BioDAOs can grant partial ownership of their research results, allowing more stakeholders to benefit from future scientific breakthroughs, while retaining control over key decisions and potentially earning revenue from the use of their data.

为了激励对其网络做出明确、可衡量的贡献，BIO 以额外 BIO 代币的形式向实现关键里程碑的 BioDAO 发放“bio/acc 奖励”。除了这些激励措施之外，BioDAO 还可以将其知识产权（从研究数据到专利）代币化。通过发行 IP 代币，BioDAO 可以授予其研究成果的部分所有权，让更多利益相关者从未来的科学突破中受益，同时保留对关键决策的控制权，并有可能通过使用其数据获得收入。

Beyond direct incentives, the overall value of the network grows through token distribution and the liquidity owned by the protocol. Grants to new BioDAOs are exchanged for a small stake in their tokens, while liquidity pool fees flow back into the treasury. As BioDAOs mature and produce tangible results, the total value of these assets increases, reinforcing a virtuous cycle of funding, growth, and innovation.

除了直接激励之外，网络的整体价值还通过代币分配和协议拥有的流动性来增长。对新 BioDAO 的资助可换取其代币的少量股份，而流动性池费用则回流至金库。随着 BioDAO 的成熟并产生切实的成果，这些资产的总价值会增加，从而加强融资、增长和创新的良性循环。

BioDAOs in the BIO Network

BIO 网络中的 BioDAO

Currently, there are eight BioDAOs active in the BIO Network, each focusing on a specific area of research. Their diverse pursuits span from extending human lifespan and exploring quantum biology to tackling hair loss and advancing synthetic biology for climate solutions.

目前，BIO 网络中有 8 个活跃的 BioDAO，每个 BioDAO 都专注于特定的研究领域。他们的追求多种多样，从延长人类寿命和探索量子生物学到解决脱发问题和推进合成生物学以解决气候问题。

1. VitaDAO: Launched in 2021, VitaDAO aims to support research into extending human lifespan. Backed by Pfizer Ventures and Balaji Srinivasan, it delves into the biological mechanisms of aging, including neurodegenerative diseases.

1. VitaDAO：VitaDAO 于 2021 年推出，旨在支持延长人类寿命的研究。在辉瑞风险投资公司和 Balaji Srinivasan 的支持下，它深入研究衰老的生物学机制，包括神经退行性疾病。

2. Quantum Biology DAO: This DAO explores how weak magnetic fields affect cells at the quantum level. In collaboration with the Institute for Quantum Biology, it aims to develop quantum microscopes to open up new avenues for longevity research, drug discovery, and more.

2. 量子生物学 DAO：该 DAO 探索弱磁场如何在量子水平上影响细胞。它与量子生物学研究所合作，旨在开发量子显微镜，为长寿研究、药物发现等开辟新途径。

3. HairDAO: Bringing together patients,

3. HairDAO：将患者聚集在一起，